Purple Biotech Cash Flow Statement (2014-2026) | PPBT

Cash Flow Statement Sep2014 Dec2014 Sep2015 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-0.00M0.15M0.51M-7.32M-3.55M-4.85M6.04M-4.90M-5.16M-5.05M15.10M-3.78M-2.42M-0.67M-0.41M-0.46M-1.09M-1.30M-23.64M-0.09M
Depreciation and Depletion (Quarter)
0.06M0.06M0.12M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.04M0.04M0.05M0.06M0.05M0.07M
Share-based Compensation (Quarter)
0.68M0.39M0.70M0.31M0.56M0.71M0.84M0.75M0.49M0.45M0.18M0.27M0.22M0.13M-0.03M0.09M0.06M0.20M-0.04M0.09M
Cash from Discontinued Operations (Quarter)
0.02M-0.03M-0.37M
Non-cash Items (Quarter)
-2.89M-2.59M-6.96M-6.97M-2.98M-4.33M-5.71M-4.32M-4.59M-5.25M-6.04M-4.15M-2.92M-1.95M-1.01M-1.27M-1.13M-1.11M-2.95M-2.09M
Cash from Operations (Quarter)
-5.10M-2.91M-6.88M-5.20M-3.70M-3.62M-4.21M-6.06M-5.22M-3.66M-4.98M-5.08M-3.98M-3.29M-2.01M-1.98M-1.54M-1.07M-1.07M-3.12M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter)
0.06M0.06M0.12M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.04M0.04M0.05M0.06M0.05M0.07M
Change in Working Capital
Change in Account Payables (Quarter)
0.64M-0.14M-0.34M0.17M-0.26M1.62M-0.73M0.25M-0.88M1.04M0.92M-0.05M-0.44M-1.14M-0.45M-0.59M-0.23M-0.02M1.29M-1.24M
Change in Accured Expenses (Quarter)
-3.24M-0.08M1.20M2.73M-1.30M-0.93M1.64M-1.50M0.03M0.21M0.18M-0.67M-0.66M-0.34M-0.67M0.13M-0.23M-0.00M0.30M0.30M
Other Working Capital Changes (Quarter)
-0.04M-0.04M-0.08M-0.04M-0.04M-0.04M-0.04M-0.04M-0.04M-0.04M-0.04M-0.04M-0.05M-0.04M-0.05M-0.05M-0.04M-0.06M-0.06M-0.06M
Investing Activities
Capital Expenditures (Quarter)
-0.08M-0.01M-0.01M-0.01M-0.01M-0.01M0.05M-0.00M-0.00M0.00M0.01M
Sales of Property, Plant and Equipment (Quarter)
0.19M0.22M0.07M0.32M-0.15M
Acquisitions (Quarter)
-3.55M3.55M
Change in Acquisitions & Divestments (Quarter)
1.40M20.30M-6.00M-16.78M22.14M15.80M0.00M0.00M-0.01M-0.00M0.00M-0.01M-0.01M0.01M0.00M
Cash from Investing Activities (Quarter)
5.46M1.57M6.63M17.72M-5.98M0.18M8.00M12.60M0.20M1.01M0.07M0.31M0.09M0.07M0.04M0.26M0.11M0.37M-0.10M0.04M
Financing Activities
Other financing activities (Quarter)
6.40M17.80M8.00M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
Change in Capital Stock
Shares Issued (Quarter)
Misc.
Cash from Financing Activities (Quarter)
-0.06M-0.06M0.48M0.16M0.29M0.57M0.09M0.26M0.37M0.57M4.25M0.27M0.43M2.13M3.94M0.10M0.37M5.57M0.30M-0.06M
Exchange Rate Effect (Quarter)
0.02M-0.00M-0.01M-0.03M-0.15M-0.06M0.08M0.05M-0.02M-0.02M0.05M-0.00M-0.01M0.00M-0.01M0.04M-0.02M-0.00M-0.01M
Change in Cash (Quarter)
0.32M-1.42M1.78M12.68M-9.38M-2.88M3.87M6.80M-4.66M-2.08M-0.66M-4.50M-3.46M-1.09M1.96M-1.62M-1.07M4.87M-0.87M-3.14M
Free Cash Flow (Quarter)
-5.02M-2.90M-6.87M-5.19M-3.69M-3.62M-4.27M-6.06M-5.22M-3.66M-4.99M-5.08M-3.98M-3.29M-2.01M-1.98M-1.54M-1.07M-1.07M-3.12M
Net Cash Flow (Quarter)
0.30M-1.39M0.23M12.68M-9.38M-2.88M3.87M6.80M-4.66M-2.08M-0.66M-4.50M-3.46M-1.09M1.96M-1.62M-1.07M4.87M-0.87M-3.14M